Clinical Trial Update: Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing low-dose rosuvastatin plus ezetimibe versus high-dose rosuvastatin in acute myocardial infarction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: Kiyuk Chang, MD,PhD | Conditions: Myocardial Infarction, Statin Adverse Reaction | Phase 4 | Status: RECRUITING